FABP5 and skin disorder: Surprisingly, when treated with MC903, we observed that conditional deletion of FABP5 from neither keratinocytes nor myeloid cells was sufficient to recapitulate the exacerbated dermatitis observed in germline FABP5 KO mice (Figure 2H, 2I).